All Stories

  1. Captured: The Body Count and the Blind Spot—An Introduction to OVERREACH: The Deadly Price of Regulatory Surveillance

    Article • July 2026, MDPI AG

    Dr Richard H Parrish

  2. A Portable, Patient-Possessed Health Record: Architecture for Care Coordination as an Alternative to Centralized Data Aggregation

    Article • Pharmacy, July 2026, MDPI AG

    Dr Richard H Parrish

  3. Origins of Surveillance Technology in the United States

    Article • July 2026, MDPI AG

    Dr Richard H Parrish

  4. Comment on “ ACCP Position Statement on Direct‐to‐Consumer Advertising of Prescription Medications”

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, June 2026, Wiley

    Dr Richard H Parrish

  5. Introduction to Overreach: The Deadly Price of Regulatory Surveillance Captured: How Medicine Became an Instrument of State Power

    Article • April 2026, MDPI AG

    Dr Richard H Parrish

  6. Captured: How Medicine Became an Instrument of State Power An Introduction to Remedy: How Drug Regulation Kills Patients

    Article • April 2026, MDPI AG

    Dr Richard H Parrish

  7. Genomic Medicine and Individual Autonomy: Reflections on Knowledge Societies and Governmentality

    Article • International Journal of Environmental Research and Public Health, February 2026, MDPI AG

    Dr Richard H Parrish

  8. Risk-Stratified Venous Thromboembolism Chemoprophylaxis After Total Joint Arthroplasty: Evaluation of an Institutional Approach

    Article • Journal of Clinical Medicine, January 2025, MDPI AG

    Dr Richard H Parrish

  9. A causal model for predicting the impact of pharmacotherapy on colorectal surgery outcomes

    Article • Extremophiles, November 2024, Wiley

    Dr Richard H Parrish

  10. Enhanced recovery after surgery (ERAS®) Society abdominal and thoracic surgery recommendations: A systematic review and comparison of guidelines for perioperative and pharmacotherapy core items

    Article • Extremophiles, February 2024, Wiley

    Dr Richard H Parrish

  11. Effect of Pharmacoprophylaxis on Postoperative Outcomes in Adult Elective Colorectal Surgery: A Multi-Center Retrospective Cohort Study within an Enhanced Recovery after Surgery Framework

    Article • October 2023, MDPI AG

    Dr Richard H Parrish

  12. How Compounding Pharmacies Fill Critical Gaps in Pediatric Drug Development Processes: Suggested Regulatory Changes to Meet Future Challenges

    Article • Children, December 2022, MDPI AG

    Dr Richard H Parrish

  13. Opportunities for Comprehensive Medication Management (CMM) for Children with Special Healthcare Needs and Medical Complexity (CSHCN-CMC): The Methodology of a Prospective Case Series within a Collaborative Practice Agreement (CPA)

    Article • November 2022, MDPI AG

    Dr Richard H Parrish

  14. Creating Data Standards to Support the Electronic Transmission of Compounded Nonsterile Preparations (CNSPs): Perspectives of a United States Pharmacopeia Expert Panel

    Article • Children, September 2022, MDPI AG

    Dr Richard H Parrish

  15. Positive Patient Postoperative Outcomes with Pharmacotherapy: A Narrative Review including Perioperative-Specialty Pharmacist Interviews

    Article • Journal of Clinical Medicine, September 2022, MDPI AG

    Dr Richard H Parrish

  16. Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update

    Article • Pharmaceutics, May 2022, MDPI AG

    Dr Richard H Parrish

  17. Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update

    Article • April 2022, MDPI AG

    Dr Richard H Parrish

  18. Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update

    Article • March 2022, MDPI AG

    Dr Richard H Parrish

  19. Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update

    Article • March 2022, MDPI AG

    Dr Richard H Parrish

  20. Pharmacotherapeutic prophylaxis and post-operative outcomes within an Enhanced Recovery After Surgery (ERAS®) program: A randomized retrospective cohort study

    Article • Annals of Medicine and Surgery, January 2022, Wolters Kluwer Health

    Dr Richard H Parrish

  21. Biosimilar Interchangeability and Emerging Treatment Strategies for Inflammatory Bowel Diseases: A Commentary

    Article • Gastroenterology Insights, June 2021, MDPI AG

    Dr Richard H Parrish

  22. Book Review: Cohn, S.L. (Ed.). Decision Making in Perioperative Medicine: Clinical Pearls. (New York: McGraw-Hill), 2021. ISBN: 978-1-260-46810-6

    Article • Healthcare, June 2021, MDPI AG

    Dr Richard H Parrish

  23. The Perioperative Surgical Home in Pediatrics: Improve Patient Outcomes, Decrease Cancellations, Improve HealthCare Spending and Allocation of Resources during the COVID-19 Pandemic

    Article • Healthcare, August 2020, MDPI AG

    Dr Richard H Parrish

  24. Expanding Pharmacotherapy Data Collection, Analysis, and Implementation in ERAS® Programs—The Methodology of an Exploratory Feasibility Study

    Article • Healthcare, August 2020, MDPI AG

    Dr Richard H Parrish

  25. Minimizing Medication Errors from Electronic Prescription Transmission—Digitizing Compounded Drug Preparations

    Article • Pharmacy, November 2019, MDPI AG

    Dr Richard H Parrish

  26. Making Meaningful Improvements in Pharmacotherapy and Medication Management for Children and Youth—A Modest Proposal

    Article • Children, October 2019, MDPI AG

    Dr Richard H Parrish

  27. Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population Health Perspective

    Article • Children, April 2019, MDPI AG

    Dr Richard H Parrish

  28. Toolkit for Population Health Initiatives Around the Globe Related to Collaborative Comprehensive Medication Management for Children and Youth

    Article • Children, April 2019, MDPI AG

    Dr Richard H Parrish

  29. Where are the Ambulatory Care Pediatric Pharmacists?

    Article • Children, February 2019, MDPI AG

    Dr Richard H Parrish

  30. What Is a Formulary, Anyway? Part 2

    Article • Pharmacy, July 2018, MDPI AG

    Dr Richard H Parrish

  31. Lecture 2—What Is a Formulary, Anyway? (Or the Cliff Notes Version of Drug Stewardship and Expense Control)

    Article • Pharmacy, July 2018, MDPI AG

    Dr Richard H Parrish

  32. Lecture 3—Measuring Pharmacy’s Work in the 21st Century

    Article • Pharmacy, July 2018, MDPI AG

    Dr Richard H Parrish

  33. Lecture 1—Justification of the Value of Clinical Pharmacy Services and Clinical Indicators Measurements—Introductory Remarks from a Traveler on a 40-Year Wayfaring Journey with Clinical Pharmacy and Pharmaceutical Care

    Article • Pharmacy, June 2018, MDPI AG

    Dr Richard H Parrish

  34. Briefing Note: Proceedings of the Singapore National Clinical Pharmacy Colloquium—Health Manpower Development Planning

    Article • Pharmacy, June 2018, MDPI AG

    Dr Richard H Parrish

  35. Positioning a Paediatric Compounded Non-Sterile Product Electronic Repository (pCNPeRx) within the Health Information Technology Infrastructure

    Article • Pharmacy, December 2015, MDPI AG

    Dr Richard H Parrish

  36. Creating a Distinct Medication-Use System for Children at the Point of Care: The Time is Now

    Article • Pharmacy, June 2015, MDPI AG

    Dr Richard H Parrish, Ibolja Cernak

  37. Optimizing Effectiveness in Electronic Prescriptions for Pediatric Outpatients: A Call for Responsive Action

    Article • Pharmacy, September 2014, MDPI AG

    Dr Richard H Parrish

  38. Recommendations for Meeting the Pediatric Patient's Need for a Clinical Pharmacist: A Joint Opinion of the Pediatrics Practice and Research Network of the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, February 2013, Wiley

    Dr Richard H Parrish

  39. Recommendations for Meeting the Pediatric Patient's Need for a Clinical Pharmacist: A Joint Opinion of the Pediatrics Practice and Research Network of the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group

    Article • The Journal of Pediatric Pharmacology and Therapeutics, December 2012, Pediatric Pharmacy Advocacy Group

    Dr Richard H Parrish

  40. Effect of Carbamazepine Initiation and Discontinuation on Antithrombotic Control in a Patient Receiving Warfarin: Case Report and Review of the Literature

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, November 2006, Wiley

    Dr Richard H Parrish

  41. Letters for Vol. 69, Issue 1

    Article • American Journal of Pharmaceutical Education, September 2005, American Journal of Pharmaceutical Education

    Dr Richard H Parrish

  42. Letters for Vol. 68, Issue 4

    Article • American Journal of Pharmaceutical Education, September 2004, American Journal of Pharmaceutical Education

    Dr Richard H Parrish

  43. The Relationships Between Profitability, Inventory Efficiency, and Gross Margin Return on Investment in Alabama Community Pharmacies

    Article • Journal of Pharmaceutical Marketing & Management, October 1986, The Haworth Press

    Dr Richard H Parrish

  44. The Relationships Between Profitability, Inventory Efficiency, and Gross Margin Return on Investment in Alabama Community Pharmacies

    Article • Journal of Pharmaceutical Marketing & Management, January 1986, Taylor & Francis

    Dr Richard H Parrish

  45. On Drug Therapy and Management of Asthmatics

    Article • American Journal of Public Health, December 1980, American Public Health Association

    Dr Richard H Parrish